Edwards Lifesciences Corp Stockholders Equity

Quick Answer

Edwards Lifesciences Corp reported Stockholders Equity of $10.34 billion for the year ending 2025.

  • Edwards Lifesciences Corp showed an increase of +3.4% in Stockholders Equity from 2024 to 2025.
  • This data is from Edwards Lifesciences Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2011: $1.35 billion | Q1 2012: $1.39 billion | Q2 2012: $1.43 billion | Q3 2012: $1.54 billion | Q1 2013: $1.59 billion | Q2 2013: $1.58 billion | Q3 2013: $1.44 billion | Q1 2014: $1.34 billion | Q2 2014: $1.91 billion | Q3 2014: $2.04 billion | Q1 2015: $2.21 billion | Q2 2015: $2.29 billion | Q3 2015: $2.42 billion | Q1 2016: $2.30 billion | Q2 2016: $2.47 billion | Q3 2016: $2.69 billion | Q1 2017: $2.74 billion | Q2 2017: $2.94 billion | Q3 2017: $3.16 billion | Q1 2018: $3.25 billion | Q2 2018: $3.16 billion | Q3 2018: $3.36 billion | Q1 2019: $3.45 billion | Q2 2019: $3.50 billion | Q3 2019: $3.81 billion | Q1 2020: $3.90 billion | Q2 2020: $3.84 billion | Q3 2020: $4.21 billion | Q1 2021: $4.66 billion | Q2 2021: $5.13 billion | Q3 2021: $5.54 billion | Q1 2022: $5.84 billion | Q2 2022: $5.94 billion | Q3 2022: $6.22 billion | Q1 2023: $5.98 billion | Q2 2023: $6.38 billion | Q3 2023: $6.66 billion | Q1 2024: $7.12 billion | Q2 2024: $7.44 billion | Q3 2024: $9.55 billion | Q1 2025: $10.13 billion | Q2 2025: $10.55 billion | Q3 2025: $10.21 billion.
  • Over the full 16 years of available data (2010 to 2025), Edwards Lifesciences Corp's Stockholders Equity has grown by 690.2%.
  • Historical annual values: Fiscal year 2025: $10.34 billion | Fiscal year 2024: $10.00 billion | Fiscal year 2023: $6.65 billion | Fiscal year 2022: $5.81 billion | Fiscal year 2021: $5.84 billion | Fiscal year 2020: $4.57 billion | Fiscal year 2019: $4.15 billion | Fiscal year 2018: $3.14 billion | Fiscal year 2017: $2.96 billion | Fiscal year 2016: $2.62 billion | Fiscal year 2015: $2.50 billion | Fiscal year 2014: $2.19 billion | Fiscal year 2013: $1.54 billion | Fiscal year 2012: $1.47 billion | Fiscal year 2011: $1.33 billion | Fiscal year 2010: $1.31 billion.
  • Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: